← Home / Universe Pharmaceuticals INC (UPC)
Stock Analysis
Universe Pharmaceuticals INC (UPC)
UPC
UPC · Market data
5.34 -7.84%
52W Range Position
31%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-10 00:01 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 12.18. Holding above 4.02 keeps the current thesis intact.
⚖️
✓
Fundamentals
Insufficient / Negative
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
4.02
↗
Break Above
Confirmation improves above resistance.
12.18
🎯
Next Objective
Pattern-derived target if setup continues.
4.82
×
Thesis Break
Scenario weakens below invalidation.
Below 4.02
What's Driving UPC?
📈 Technical recovery is improving
Momentum is Neutral. Watch 12.18 for confirmation and 4.02 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 4.02
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
53.2
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 4.02 and resistance at 22.51. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
UPC · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-09
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$19.5M
Company size
EV
$7.2B
Debt-adjusted value
P/E
-0.0
Not meaningful
P/S
0.0
Low sales multiple
P/B
0.7
Low book multiple
EV/Sales
0.4
Low sales multiple
EV/EBIT
-2.5
Not meaningful
P/FCF
-0.0
Not meaningful
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Negative
≈
Cash Flow
Mixed
⚖
Balance Sheet
Manageable
💵 Revenue
12.88M
≈ Insufficient
📈 Net Income
-13.10M
↘ Negative
🧮 EPS (Basic)
-3.59
↘ Negative
Universe Pharmaceuticals INC
Related Opportunities